Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Presidio Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7598
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, faldaprevir and non-nucleoside inhibitor. Its lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride has completed phase 1 clinical studies in both healthy volunteers and HCV patients. Presidio Pharmaceuticals’ second pan-genotypic HCV inhibitor PPI-383 is a NS5B non-nucleoside inhibitor currently being evaluated in phase 1 studies. The company also has an extensive intellectual property portfolio for its HCV programs. Presidio Pharmaceuticals is headquartered in San Francisco, California, the US.

Presidio Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Presidio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Presidio Pharma Raises Additional USD13 Million in Series D Venture Financing 11
Presidio Pharma Raises US$8.6 Million In Series D Financing 12
Presidio Pharma Raises Additional US$8 Million In Series C Financing 13
Private Equity 14
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 14
Licensing Agreements 16
Pharco Pharma Enters into Licensing Agreement with Presidio Pharma for PPI-668 16
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 17
Presidio Pharmaceuticals Inc – Key Competitors 18
Presidio Pharmaceuticals Inc – Key Employees 19
Presidio Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Presidio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Presidio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Presidio Pharma Raises Additional USD13 Million in Series D Venture Financing 11
Presidio Pharma Raises US$8.6 Million In Series D Financing 12
Presidio Pharma Raises Additional US$8 Million In Series C Financing 13
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 14
Pharco Pharma Enters into Licensing Agreement with Presidio Pharma for PPI-668 16
Ascletis Enters into Licensing Agreement with Presidio Pharma for PPI-668 17
Presidio Pharmaceuticals Inc, Key Competitors 18
Presidio Pharmaceuticals Inc, Key Employees 19

List of Figures
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Presidio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Presidio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Denbury Resources Inc (DNR):企業の財務・戦略的SWOT分析
    Denbury Resources Inc (DNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • California Resources Corp (CRC):企業の財務・戦略的SWOT分析
    California Resources Corp (CRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • Stryker Corporation:企業のM&A・事業提携・投資動向
    Stryker Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stryker Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Caldera Health Ltd:製品パイプライン分析
    Summary Caldera Health Ltd (Caldera) is a medical device company that develops prostate cancer diagnostic tools. The company develops prostate cancer diagnostic tools to detect and monitor the cancer disease. It also develops proscanZ and auditor tests based on the enzyme linked immunoassays or ELIS …
  • YPF SA:企業のM&A・事業提携・投資動向
    YPF SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's YPF SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Chubu Electric Power Co Inc (9502)-エネルギー分野:企業M&A・提携分析
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity from nuclear, hydro, solar, biomass, wind, coal, fuel oil, and natural gas sources. Chubu has interests in upstream …
  • LIC of India:企業の戦略・SWOT・財務分析
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Janssen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Ashok Leyland Limited:企業のM&A・事業提携・投資動向
    Ashok Leyland Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ashok Leyland Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CME Group Inc.:戦略・SWOT・企業財務分析
    CME Group Inc. - Strategy, SWOT and Corporate Finance Report Summary CME Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lassonde Industries Inc.:戦略・SWOT・企業財務分析
    Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Lassonde Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Antrim Energy Inc. (AEN)-石油・ガス分野:企業M&A・提携分析
    Summary Antrim Energy Inc. (Antrim Energy) is an oil and gas exploration and production company. It conducts the acquisition, exploration, development and production of oil and natural gas properties. The company carries out its operations in the UK North Sea and Ireland. In UK, the company holds op …
  • NTT Communications Corporation:戦略・SWOT・企業財務分析
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Viskase Companies Inc (VKSC):企業の財務・戦略的SWOT分析
    Viskase Companies Inc (VKSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • Evolution Petroleum Corp (EPM):企業の財務・戦略的SWOT分析
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Pyxus International Inc:企業の戦略・SWOT・財務情報
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆